RAYTHEON CO's ticker is RTN and the CUSIP is 755111507. A total of 961 filers reported holding RAYTHEON CO in Q1 2016. The put-call ratio across all filers is 1.58 and the average weighting 0.3%.
About RAYTHEON CO
Raytheon Co. is a leading technology and innovation company that specializes in defense, civil government, and cybersecurity solutions. With a history spanning over 90 years, Raytheon has established itself as a trusted partner to governments and businesses around the world.
One of the key strengths of Raytheon is its focus on research and development. The company invests heavily in cutting-edge technologies and has a strong track record of delivering innovative solutions to its customers. This has helped Raytheon to stay ahead of the competition and maintain its position as a leader in the industry.
Another factor that sets Raytheon apart is its commitment to sustainability. The company has set ambitious goals to reduce its environmental impact and has implemented a number of initiatives to achieve these goals. This includes reducing greenhouse gas emissions, conserving water, and minimizing waste.
Despite the challenges posed by the COVID-19 pandemic, Raytheon has continued to perform well. The company reported strong financial results in the first quarter of 2021, with net sales of $15.2 billion and earnings per share of $0.90. This is a testament to the resilience of the company and its ability to adapt to changing market conditions.
Overall, Raytheon is a company that is well-positioned for long-term success. With its focus on innovation, sustainability, and strong financial performance, Raytheon is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $3,135,000 | -8.9% | 16,800 | -21.1% | 3.19% | -25.3% |
| Q2 2017 | $3,440,000 | +59.9% | 21,303 | +51.1% | 4.27% | +256.1% |
| Q1 2017 | $2,151,000 | -0.3% | 14,103 | -7.2% | 1.20% | -12.5% |
| Q4 2016 | $2,158,000 | -46.7% | 15,200 | -48.8% | 1.37% | -50.7% |
| Q3 2016 | $4,045,000 | -13.5% | 29,715 | -13.7% | 2.78% | +37.1% |
| Q2 2016 | $4,679,000 | -11.3% | 34,415 | -20.0% | 2.03% | -4.9% |
| Q1 2016 | $5,275,000 | -1.5% | 43,015 | 0.0% | 2.13% | +8.7% |
| Q4 2015 | $5,357,000 | +113.2% | 43,015 | +87.0% | 1.96% | +22.9% |
| Q3 2015 | $2,513,000 | – | 23,000 | – | 1.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brick & Kyle, Associates | 62,251 | $4,480 | 2.38% |
| Providence Wealth Advisors, LLC | 6,475 | $462,478 | 0.52% |
| PHYSICIANS FINANCIAL SERVICES, INC. | 14,579 | $1,049 | 0.43% |
| Shakespeare Wealth Management, LLC | 8,383 | $603,325 | 0.21% |